Man Group PLC Amryt Pharma PLC Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$6.8 - $8.01 $15,640 - $18,423	-2,300 Reduced 0.18%	1,309,234 $9.06 Million
Q2 2022 Aug 15, 2022	BUY	$6.85 - $8.87 $258,519 - $334,753	37,740 Added 2.96%	1,311,534 $9.17 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $10.86 $904,251 - $1.56 Million	143,532 Added 12.7%	1,273,794 $10.5 Million
Q4 2021 Feb 14, 2022	BUY	$9.44 - $12.24 $1.89 Million - $2.46 Million	200,596 Added 21.58%	1,130,262 $12.2 Million
Q3 2021 Nov 15, 2021	BUY	$9.63 - $12.47 $8.95 Million - $11.6 Million	929,666 New	929,666 $11.2 Million

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.